Analysis of coagulability and coagulation factors before and after the development of symptoms in patients with physical urticaria
Not Applicable
- Conditions
- physical urticaria
- Registration Number
- JPRN-UMIN000002585
- Lead Sponsor
- Department of Dermatology, Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnant or lactating women or women of child bearing potential not using contraception 2. Patients with diseases as follows. Liver disease, psychological illness, convulsive and other seizure, heart disease, hemoglobinopathy, hemophilia, uncontrolled diabetes, and autoimmune diseases. 3. Patients who use medications that influence the coagulation and fibrinolytic cascade. 4. Others whom the physician judges are not suitable as subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurements regarding coagulability, coagulation factors and levels of blood histamine before and after the development of symptoms
- Secondary Outcome Measures
Name Time Method